11.2 USP <797> Sterile Compounding & Cleanroom Specifications
Key Takeaways
- Cleanroom engineering controls require ISO Class 5 air quality (<3,520 particles/m³) in the Primary Engineering Control (PEC), ISO Class 7 (<352,000 particles/m³) in the buffer room, and ISO Class 8 (<3,520,000 particles/m³) in a positive-pressure anteroom.
- A minimum positive pressure differential of +0.020 inches water column (+5 Pa to +20 Pa) must be continuously maintained from the buffer room outward to the anteroom and from the anteroom to unclassified pharmacy spaces, monitored and logged daily.
- Updated USP <797> categorizes sterile preparations into Category 1 CSPs (prepared in a Segregated Compounding Area with BUDs ≤ 12 hours room temp or ≤ 24 hours refrigerated) and Category 2 CSPs (prepared in an ISO 7 cleanroom suite with BUDs determined by starting component sterility, testing, and storage conditions).
- Strict garbing sequence flows from dirtiest to cleanest: shoe covers, head and beard covers, face mask/eye shield, 30-second hand and forearm wash, non-shedding gown, sanitization with sterile 70% IPA, and sterile powder-free gloves donned over the cuffs.
- Personnel compounding sterile preparations must pass initial Gloved Fingertip Testing with 3 consecutive samples yielding 0 CFUs and initial Media-Fill Testing with zero growth after 14 days of incubation, followed by mandatory re-evaluation at least every 6 months.
11.2 USP <797> Sterile Compounding & Cleanroom Specifications
Sterile pharmaceutical compounding is among the highest-risk operational disciplines in pharmacy practice. Compounded Sterile Preparations (CSPs)—including intravenous admixtures, total parenteral nutrition (TPN) solutions, ophthalmic drops, and intrathecal injections—bypass the body's natural immunological defenses (skin and gastrointestinal mucosa). Contamination by viable microorganisms, endotoxins, or airborne particulate matter can result in catastrophic bloodstream infections, meningitis, and death.
In New Jersey, sterile compounding standards are governed by the United States Pharmacopeia General Chapter <797> (Pharmaceutical Compounding – Sterile Preparations) and the comprehensive administrative regulations promulgated by the New Jersey State Board of Pharmacy at N.J.A.C. 13:39-11. Pharmacists, pharmacy managers, and compounding personnel must adhere strictly to cleanroom engineering classifications, airflow dynamics, personnel qualification regimens, and environmental monitoring protocols.
Cleanroom Air Quality Architecture & Engineering Controls
Controlling airborne particulate matter and viable bioburden requires a cascaded architecture of primary and secondary engineering controls. Air quality is classified according to the International Organization for Standardization (ISO) standards based on the maximum allowable number of airborne particles ≥ 0.5 micrometers (µm) per cubic meter of air.
Cleanroom Facility Cascaded Pressures
Unclassified Area ISO Class 8 Anteroom ISO Class 7 Buffer Room
[ General Pharmacy ] [ Hand Hygiene & Garbing ] [ Primary Engineering Control ]
Ambient Air ───► ≥ +0.020" w.c. ───► ≥ +0.020" w.c.
(>3,520,000 part/m³) (≤3,520,000 part/m³) (≤352,000 part/m³)
│
▼
ISO Class 5 (PEC)
[ Laminar Flow Hood ]
(≤3,520 part/m³)
Primary Engineering Controls (PECs) — ISO Class 5
The Primary Engineering Control is the device or zone that provides an ISO Class 5 environment where sterile manipulations are performed. Common PECs include:
- Laminar Airflow Workbenches (LAFW): Provide unidirectional, non-turbulent airflow across the Direct Compounding Area (DCA). Horizontal LAFW sweeps air from the back of the cabinet toward the operator (used exclusively for non-hazardous compounding). Vertical LAFW blows air downward from the ceiling of the hood.
- Compounding Aseptic Isolators (CAI): Positive-pressure glove boxes utilizing HEPA filtration to maintain ISO Class 5 air quality while isolating the compounding chamber from the room environment.
- Direct Compounding Area (DCA) & "First Air": The critical area within the ISO Class 5 PEC where critical sites (needle hubs, vial septa, ampule necks) are exposed to unidirectional, uncontaminated First Air emerging directly from the High-Efficiency Particulate Air (HEPA) filter. Critical sites must never be occluded or shadowed from First Air.
Secondary Engineering Controls (SECs) — ISO Class 7 and ISO Class 8
The Secondary Engineering Control is the physical cleanroom suite that houses the PEC and controls the background environment.
- Buffer Room (Cleanroom): The room in which the PEC is physically located. It must maintain ISO Class 7 air quality (no more than 352,000 particles/m³ of 0.5 µm or larger).
- Anteroom (Ante-Area): An area located immediately adjacent to the buffer room where personnel perform hand hygiene, garbing, order entry, and component decontamination.
- For positive-pressure (non-hazardous) cleanroom suites, the anteroom must maintain at least ISO Class 8 air quality (no more than 3,520,000 particles/m³).
- If the anteroom opens into a negative-pressure hazardous drug buffer room, it must maintain ISO Class 7 air quality.
Differential Pressure Standards
To prevent the ingress of unclassified air into critical compounding zones, a continuous positive pressure differential must be maintained across cleanroom boundaries:
- Positive Differential Pressure: A minimum pressure differential of +0.020 inches water column (+5 Pa to +20 Pa) must be maintained from the ISO Class 7 buffer room outward to the anteroom, and from the anteroom outward to unclassified pharmacy areas.
- Daily Pressure Monitoring: Differential pressure must be monitored and recorded at least once daily on every operational day using continuous pressure gauges (such as Magnehelic gauges) or automated building monitoring sensors.
| Cleanroom Zone | ISO Classification | Maximum Particle Limit (≥ 0.5 µm/m³) | Air Pressure Requirement |
|---|---|---|---|
| PEC / Direct Compounding Area | ISO Class 5 | ≤ 3,520 | Unidirectional airflow within the hood |
| Buffer Room (Cleanroom) | ISO Class 7 | ≤ 352,000 | Positive ≥ +0.020" w.c. relative to anteroom |
| Anteroom (Non-Hazardous Suite) | ISO Class 8 | ≤ 3,520,000 | Positive ≥ +0.020" w.c. relative to unclassified space |
| Anteroom (Hazardous Suite) | ISO Class 7 | ≤ 352,000 | Positive to general areas; negative to buffer room |
| Unclassified General Area | Unclassified | > 3,520,000 | Baseline ambient atmospheric pressure |
Updated USP <797> Compounded Sterile Preparation (CSP) Categories
The updated USP General Chapter <797> eliminated the legacy "low, medium, and high risk" tiers, establishing an objective classification system based on environmental controls, starting material sterility, and release testing.
Category 1 CSPs
- Compounding Environment: Compounded in an unclassified Segregated Compounding Area (SCA) or inside a PEC that does not reside in an ISO Class 7 buffer room.
- SCA Specifications: An SCA must feature defined physical boundaries, cleanable non-shedding surfaces, and must not be located adjacent to construction sites, unsealed doors, or plumbing sinks. A sink must not be within 1 meter (3.3 feet) of the PEC.
- Beyond-Use Dates (BUDs):
- Controlled room temperature (20°C to 25°C): ≤ 12 hours;
- Refrigerated (2°C to 8°C): ≤ 24 hours;
- Freezing is not permitted for Category 1 CSPs.
Category 2 CSPs
- Compounding Environment: Compounded in a certified cleanroom suite featuring an ISO Class 5 PEC located inside an ISO Class 7 buffer room accessed through an ISO Class 8 anteroom.
- Beyond-Use Dating Matrix: BUDs for Category 2 CSPs vary depending on whether all starting components are sterile, whether terminal sterilization is used, whether sterility testing is performed, and the storage temperature.
| Compounding Method & Components | Sterility Testing Performed? | Controlled Room Temp (20°C to 25°C) | Refrigerated (2°C to 8°C) | Frozen (-25°C to -10°C) |
|---|---|---|---|---|
| Aseptically prepared; all starting components sterile | No (Sterility test not performed) | 4 days | 10 days | 45 days |
| Aseptically prepared; ≥ 1 non-sterile starting component | No (Sterility test not performed) | 1 day (24 hours) | 4 days | 45 days |
| Terminally sterilized; all components sterile or non-sterile | No (Sterility test not performed) | 14 days | 28 days | 45 days |
| Aseptically prepared or terminally sterilized | Yes (Passed USP <71> Sterility Test) | 45 days | 60 days | 90 days |
Category 3 CSPs
- Compounding Environment: High-performance cleanroom suite requiring validated container-closure integrity testing, validated stability studies, routine sterility testing (USP <71>), endotoxin testing (USP <85>), and continuous particulate monitoring.
- Beyond-Use Dates: Permits extended BUDs beyond Category 2 limits, up to a maximum of 180 days at room temperature or refrigerated, depending on stability data.
Immediate-Use Compounding Exemption
- Clinical Scope: Reserved strictly for urgent or emergent clinical situations where immediate administration is necessary to avoid patient harm (e.g., CPR, emergency intubation, acute trauma in an emergency department or operating room).
- Operational Restrictions:
- Administration must begin within 4 hours of the initiation of preparation;
- Involves simple aseptic transfer of no more than three (3) commercially packaged sterile products;
- Compounding personnel must use basic aseptic technique;
- If not administered immediately by the preparer, the CSP must be labeled with the patient's name, ingredients, preparer's initials, and exact 4-hour discard time;
- Hazardous drugs are strictly prohibited from immediate-use compounding.
Sequential Garbing & Aseptic Hand Hygiene Protocol
Personnel garbing must follow a rigorous, non-negotiable sequence designed to eliminate shedding of biological matter. Garbing progresses strictly from dirtiest to cleanest, starting outside the clean zone and crossing the Line of Demarcation (LOD) in the anteroom.
Sequential Garbing Order
[ Unclassified / Outer Area ] ──► Remove outer garments, jewelry, watches, nail polish/cosmetics
│
▼
[ Dirty Side of Anteroom ] ──► 1. Don dedicated shoe covers (step over Line of Demarcation)
2. Don head and facial hair covers (tuck all hair)
3. Don face mask and eye protection/face shield
│
▼
[ Hand Hygiene Sink Area ] ──► 4. Wash hands and forearms to elbows with soap for ≥30 SECONDS;
dry with lint-free wipes
│
▼
[ Clean Side of Anteroom ] ──► 5. Don non-shedding gown with snug knit cuffs
│
▼
[ Buffer Room Entry ] ──► 6. Sanitize hands with sterile 70% Isopropyl Alcohol (IPA)
7. Don STERILE, powder-free gloves over gown cuffs
8. Sanitize gloves with sterile 70% IPA; allow to dry
Detailed Garbing Steps
- Personal Preparation: Remove personal outer garments (coats, sweaters), watches, rings, bracelets, and body jewelry. Remove nail polish, artificial nails, and makeup. Natural nails must be trimmed to less than 1/4 inch.
- Shoe Covers: Don dedicated shoe covers. When crossing the Line of Demarcation, step each covered foot directly onto the clean side of the anteroom floor.
- Head and Beard Covers: Don a clean head cover and beard cover (if applicable), ensuring all hair, sideburns, and ears are completely enclosed.
- Face Mask and Eye Protection: Don a surgical face mask and eye shield or goggles.
- Hand Hygiene: Wash hands and forearms up to the elbows with warm potable water and an approved antimicrobial soap for at least 30 seconds. Use a disposable nail pick under running water to clean subungual areas. Dry hands and arms thoroughly using lint-free disposable wipes or an electronic hand dryer.
- Compounding Gown: Don a clean, non-shedding gown with snug knit or elastic cuffs and a closed neck closure.
- Buffer Room Hand Sanitization: Enter the buffer room and thoroughly rub hands with sterile 70% Isopropyl Alcohol (IPA); allow hands to air dry completely.
- Sterile Gloves: Don sterile, powder-free gloves. Glove cuffs must be pulled completely over the elastic cuffs of the gown. Apply sterile 70% IPA to the gloves and allow them to dry before touching any compounding materials.
[!CAUTION] Sterile Glove Sanitization: Applying non-sterile hand sanitizer to sterile gloves inside the PEC is a critical failure. Compounders must exclusively use sterile 70% IPA dispensed from an unopened or dedicated sterile spray container, and gloves must be re-sanitized frequently throughout compounding manipulations.
Personnel Testing & Competency Verification
Under USP <797> and N.J.A.C. 13:39-11, every individual involved in compounding sterile preparations must pass initial qualification and recurring evaluations.
1. Gloved Fingertip Testing (GFT)
- Purpose: Assesses proper garbing and gloving technique and verifies that the compounder does not introduce microbial bioburden onto sterile gloves.
- Testing Technique: Immediately after completing full garbing, without applying alcohol to gloves, the operator touches each hand (all 5 digits) onto separate agar contact plates (tryptic soy agar with neutralizers).
- Initial Qualification Standard: Compounding personnel must successfully complete three (3) consecutive samples with zero (0) Colony Forming Units (0 CFUs) on both hands before being allowed to compound CSPs independently.
- Ongoing Competency Re-evaluation: Must be repeated at least every six (6) months for Category 1 and Category 2 compounding personnel. The passing action level for ongoing re-qualification is no more than 3 CFUs total for both hands combined.
2. Media-Fill Testing (MFT)
- Purpose: Simulates the most challenging, complex aseptic manipulations performed in the facility using sterile microbiological growth media (Soybean-Casein Digest Medium / Tryptic Soy Broth) in place of active drug solutions.
- Testing Protocol: Personnel must replicate actual compounding conditions, including transferring liquids via syringes, breaking ampules, reconstituting dry powders, and attaching transfer sets.
- Incubation & Reading: Media-fill units must be incubated for 14 consecutive days (typically 7 days at 20°C to 25°C, followed by 7 days at 30°C to 35°C, or vice versa).
- Passing Standard: Any turbidity or visible microbial growth at any point during the 14-day incubation period indicates a failure. The individual cannot resume compounding until retraining and successful retesting occur.
- Testing Frequency: Initial qualification prior to compounding, then at least every six (6) months for Category 1 and Category 2 compounding.
Environmental Monitoring & Facility Certification
Cleanrooms must undergo scheduled environmental surveillance to detect air and surface contamination before it impacts patient safety:
Certification of Engineering Controls
- All PECs (LAFWs, CAIs, BSCs) and secondary engineering controls (buffer rooms, anterooms) must be certified by a qualified cleanroom certifier at least every six (6) months.
- Certification includes HEPA filter integrity leak tests, total non-viable airborne particle counts under dynamic operating conditions, and airflow velocity/volume measurements.
Viable Airborne Organism Sampling
- Volumetric air sampling using an active impaction air sampler must be conducted at least every six (6) months in all PECs, buffer rooms, and anterooms.
- Action levels requiring immediate investigation and remediation:
- ISO Class 5: > 1 CFU/m³;
- ISO Class 7: > 10 CFUs/m³;
- ISO Class 8: > 100 CFUs/m³.
Viable Surface Sampling
- Surface sampling using contact plates or swabs containing microbial neutralizing agents (lecithin and polysorbate 80) must be conducted at the end of a compounding shift.
- Surface action levels:
- ISO Class 5: > 3 CFUs/plate;
- ISO Class 7: > 5 CFUs/plate;
- ISO Class 8: > 50 CFUs/plate.
Daily Environmental Monitoring
- Temperature: Buffer room temperature must be maintained at ≤ 20°C (68°F) to inhibit fungal and microbial growth and ensure operator comfort under full garbing.
- Humidity: Relative humidity must be maintained below 60% at all times.
- Documentation: Temperature, humidity, and differential pressure must be logged at least once daily on every day the cleanroom is operational.
New Jersey 5-Year Record Retention Mandate
Under N.J.A.C. 13:39-11, the pharmacy must maintain all cleanroom certification reports, viable and non-viable environmental sampling logs, daily temperature and pressure sheets, Gloved Fingertip and Media-Fill results, and personnel training files for a minimum of five (5) years. All records must be made available immediately upon inspection by authorized New Jersey Board of Pharmacy agents.
A hospital pharmacy cleanroom suite in New Jersey is designing a new cleanroom complex for non-hazardous sterile compounding. Under USP <797> and N.J.A.C. 13:39-11, what are the mandatory air quality classifications and minimum pressure differentials required between the buffer room, anteroom, and unclassified pharmacy areas?
An intravenous satellite pharmacy located in a New Jersey ambulatory surgical center prepares a cefazolin infusion inside a laminar airflow workbench (ISO Class 5) situated within an unclassified Segregated Compounding Area (SCA). The preparation is aseptically compounded using all-sterile commercial ingredients. In the absence of sterility testing, what is the maximum Beyond-Use Date (BUD) that can be assigned under updated USP <797>?
A newly hired pharmacy technician is completing aseptic technique validation for sterile compounding in a New Jersey health-system pharmacy. According to USP <797> and Board regulations, what benchmark is required for the technician to successfully complete initial Gloved Fingertip Testing (GFT) prior to compounding CSPs independently?